Evidence map›Paper›PMID 30327780›Full record

ArticleBioMed research international2018

Screening Potential Probiotic Characteristics of

Amro Abdelazez, Heba Abdelmotaal, Smith Etareri Evivie, Sherif Melak, Fang-Fang Jia, Mir Hassan Khoso, Zong-Tao Zhu, Lu-Ji Zhang, Rokayya Sami, Xiang-Chen Meng

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. The role of GABA in type 1 diabetes.Frontiers in endocrinology · 2024
    Review
  11. Effects ofFood and waterborne parasitology · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. New Wild-TypeMicroorganisms · 2022
    Article
  18. Optimization of growth ofFrontiers in bioengineering and biotechnology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

Amro AbdelazezKey Laboratory of Dairy Science of Ministry of Education, Northeast Agricultural University, Harbin 150030, China.ORCID 0000-0001-6895-6277
Heba AbdelmotaalDepartment of Microbiology, Soil, Water, Environment, and Microbiology Research Institute, Agriculture Research Center, Giza 12619, Egypt.ORCID 0000-0002-9719-3317
Smith Etareri EvivieKey Laboratory of Dairy Science of Ministry of Education, Northeast Agricultural University, Harbin 150030, China.
Sherif MelakDepartment of Animal Science and Biotechnology, College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Fang-Fang JiaKey Laboratory of Dairy Science of Ministry of Education, Northeast Agricultural University, Harbin 150030, China.
Mir Hassan KhosoDepartment of Microbiology and Biotechnology, College of Life Sciences, Northeast Agricultural University, Harbin 150030, China.
Zong-Tao ZhuKey Laboratory of Dairy Science of Ministry of Education, Northeast Agricultural University, Harbin 150030, China.
Lu-Ji ZhangKey Laboratory of Dairy Science of Ministry of Education, Northeast Agricultural University, Harbin 150030, China.
Rokayya SamiDepartment of Food Science and Nutrition, Taif University, Taif, Al-huwayah 888, Saudi Arabia.ORCID 0000-0003-3162-9453
Xiang-Chen MengKey Laboratory of Dairy Science of Ministry of Education, Northeast Agricultural University, Harbin 150030, China.ORCID 0000-0003-1764-8519
Northeast Agricultural University · CNNanjing Agricultural University · CNTaif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes has become the third most serious threat to human health, after cancer and cardiovascular disease. Notably,

Indexed as

Levilactobacillus brevisAnimalsCaco-2 CellsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1HumansProbiotics

Identifiers

PMID30327780
PMCPMC6169223
OpenAlexW2890831321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.